• candyman337@lemmy.world
        link
        fedilink
        English
        arrow-up
        17
        ·
        edit-2
        2 days ago

        Literally the rhetoric that the Nazis used as an excuse to experiment on Jews in concentration camps

        • bryndos@fedia.io
          link
          fedilink
          arrow-up
          3
          arrow-down
          10
          ·
          2 days ago

          I don’t know much about nazis but I thought an important part of their rhetoric was to draw distinctions between types of human.

          So they’d not see “10bn humans”, they’d see maybe 100m aryan and 9.9bn “untermensch”; the latter being equivalent to rats available to be experimented on.

          I just find rats to be much more preferable, pleasant and considerate creatures than humans. I see humans as a single tier of unterratten; totally different hierarchcy.

          • lime!@feddit.nu
            link
            fedilink
            English
            arrow-up
            12
            ·
            2 days ago

            so how do you choose which humans to experiment on? bearing in mind that any sort of incentive will automatically select for a particular subset, and randomness will “obviously” need to exclude a particular subset

            • bryndos@fedia.io
              link
              fedilink
              arrow-up
              1
              arrow-down
              1
              ·
              2 days ago

              A researcher should offer a sufficient compensation package to get enough volunteers after explaining the risks. They should get independent medical advice too.

              They can still randomize within the volunteers with treatment / placebo, and maybe use quotas, but they’d just have to extend their trial period until they’d achieved a measurably representative treatment and control group and enough volunteers to test the hypothesis to the required level.

              This type of non-random sampling may very well have to be done anyway, for example if they needed the power to test efficacy and safety in all the potential dug interactions or co-morbidity scenarios. Not to mention any diagnosis requirement will also screen the sample which could be influenced by health care system resources and policies, not necessarily pure morbidity. So I think they can deal with non-random sampling in med research perfectly well.